v3.24.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net income $ 655,977 $ 428,222
Adjustment to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 91,169 89,718
Amortization of right-of-use assets 18,443 17,094
Stock-based compensation costs 42,790 38,350
(Gain) loss attributable to equity method investments (note 5) (2,040) 3,156
(Gain) loss on equity investments (note 5) 2,119 2,491
Non-cash restructuring expenses (note 11) 0 33,239
Changes in operating assets and liabilities:    
Accounts receivable (31,436) (20,269)
Inventories (77,895) 77,095
Prepaid expenses, net deferred income taxes and other current assets (43,746) (74,590)
Accounts payable, accrued expenses, income taxes payable and other (21,220) (35,391)
Net cash provided by (used in) operating activities 634,161 559,115
Cash flows from investing activities:    
Purchases of property, plant and equipment (38,484) (53,388)
Patent registration and acquisition costs (4,592) (12,036)
Business acquisitions, net of cash acquired (670) (110,688)
Purchases of investments (note 5) (2,350) (7,305)
Proceeds from exits of investments (note 5) 4,378 250
Proceeds (payments) on maturity of foreign currency contracts 7,172 (6,956)
Net cash provided by (used in) investing activities (34,546) (190,123)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net 35,260 20,507
Taxes paid related to net share settlement of equity awards (17,123) (8,022)
Purchases of treasury stock (124,991) (50,007)
Payments of business combination contingent consideration (855) (1,293)
Proceeds from borrowings, net of borrowing costs 0 105,000
Repayment of borrowings (35,000) (315,000)
Dividends paid (155,586) (141,275)
Net cash provided by (used in) financing activities (298,295) (390,090)
Effect of exchange rate changes on cash (17,737) 3,454
Net increase (decrease) in cash and cash equivalents 283,583 (17,644)
Cash and cash equivalents at beginning of period 238,361 227,891
Cash and cash equivalents at end of period 521,944 210,247
Supplemental disclosure of cash flow information:    
Income taxes paid, net of refunds 224,351 173,437
Interest paid 7,285 28,762
Fair value of assets acquired, excluding cash 0 38,520
Liabilities assumed 0 (5,401)
Goodwill on acquisition 0 77,712
Fair value of contingent consideration 1,525 1,293
Cash paid for acquisitions $ 1,525 $ 111,981

Source

10-Q PDF
XBRL